178 related articles for article (PubMed ID: 9214433)
21. Degeneracy of T cell receptor recognition of an influenza virus hemagglutinin epitope restricted by HLA-DQ and -DR class II molecules.
Jones CM; Lake RA; Lamb JR; Faith A
Eur J Immunol; 1994 May; 24(5):1137-42. PubMed ID: 7514130
[TBL] [Abstract][Full Text] [Related]
22. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule.
Hill JA; Southwood S; Sette A; Jevnikar AM; Bell DA; Cairns E
J Immunol; 2003 Jul; 171(2):538-41. PubMed ID: 12847215
[TBL] [Abstract][Full Text] [Related]
23. HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis.
Mattey DL; Dawes PT; Gonzalez-Gay MA; Garcia-Porrua C; Thomson W; Hajeer AH; Ollier WE
J Rheumatol; 2001 Feb; 28(2):232-9. PubMed ID: 11246655
[TBL] [Abstract][Full Text] [Related]
24. Modulation of promiscuous T cell receptor recognition by mutagenesis of CDR2 residues.
Brawley JV; Concannon P
J Exp Med; 1996 May; 183(5):2043-51. PubMed ID: 8642315
[TBL] [Abstract][Full Text] [Related]
25. Association of MHC and rheumatoid arthritis. Association of RA with HLA-DR4: the role of repertoire selection.
Roudier J
Arthritis Res; 2000; 2(3):217-20. PubMed ID: 11094433
[TBL] [Abstract][Full Text] [Related]
26. Major histocompatibility complex and T cell interactions of a universal T cell epitope from Plasmodium falciparum circumsporozoite protein.
Parra-López C; Calvo-Calle JM; Cameron TO; Vargas LE; Salazar LM; Patarroyo ME; Nardin E; Stern LJ
J Biol Chem; 2006 May; 281(21):14907-17. PubMed ID: 16565072
[TBL] [Abstract][Full Text] [Related]
27. Sharing of four DR-beta sequence motifs between HLA-DRB1*1601 and DRB1*1101 correlates with frequent degenerate T-cell recognition of HA306-320 peptide complexed to these two molecules.
Zeliszewski D; Dorval I; Golvano JJ; Prevost A; Borras-Cuesta F; Sterkers G
Scand J Immunol; 1996 Feb; 43(2):146-54. PubMed ID: 8633194
[TBL] [Abstract][Full Text] [Related]
28. Interplay of T lymphocytes and HLA-DR molecules in rheumatoid arthritis.
Goronzy JJ; Weyand CM
Curr Opin Rheumatol; 1993 Mar; 5(2):169-77. PubMed ID: 8452767
[TBL] [Abstract][Full Text] [Related]
29. Allele-specific variation in the degeneracy of major histocompatibility complex (MHC) restriction.
Carmichael P; Copier J; So A; Lechler R
Hum Immunol; 1997 Apr; 54(1):21-9. PubMed ID: 9154454
[TBL] [Abstract][Full Text] [Related]
30. Modeling of the TCR-MHC-peptide complex.
Michielin O; Luescher I; Karplus M
J Mol Biol; 2000 Jul; 300(5):1205-35. PubMed ID: 10903865
[TBL] [Abstract][Full Text] [Related]
31. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
[TBL] [Abstract][Full Text] [Related]
32. Shared T cell recognition sites on human histocompatibility leukocyte antigen class II molecules of patients with seropositive rheumatoid arthritis.
Goronzy J; Weyand CM; Fathman CG
J Clin Invest; 1986 Mar; 77(3):1042-9. PubMed ID: 2419361
[TBL] [Abstract][Full Text] [Related]
33. Structural model for T-cell recognition of HLA class II-associated alloepitopes.
Reinsmoen NL; Bach FH
Hum Immunol; 1990 Jan; 27(1):51-72. PubMed ID: 1689285
[TBL] [Abstract][Full Text] [Related]
34. A new type of metal recognition by human T cells: contact residues for peptide-independent bridging of T cell receptor and major histocompatibility complex by nickel.
Gamerdinger K; Moulon C; Karp DR; Van Bergen J; Koning F; Wild D; Pflugfelder U; Weltzien HU
J Exp Med; 2003 May; 197(10):1345-53. PubMed ID: 12756270
[TBL] [Abstract][Full Text] [Related]
35. Multiple epitopes of HLA-DRB1*0411 are recognized by T-cell clones originated from individuals carrying other DR4 subtypes.
Araujo HA; Dole K; Lazaro AM; Fernandez-Vina M; Stastny P
Hum Immunol; 1998 Sep; 59(9):561-70. PubMed ID: 9757912
[TBL] [Abstract][Full Text] [Related]
36. Structural motifs in rheumatoid T-cell receptors.
Keiber-Emmons T; Fang Q; Cai W; Friedman SM; Crow MK; Lotke P; Williams WV
DNA Cell Biol; 1998 Feb; 17(2):133-49. PubMed ID: 9502430
[TBL] [Abstract][Full Text] [Related]
37. Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire.
Muraro PA; Vergelli M; Kalbus M; Banks DE; Nagle JW; Tranquill LR; Nepom GT; Biddison WE; McFarland HF; Martin R
J Clin Invest; 1997 Jul; 100(2):339-49. PubMed ID: 9218510
[TBL] [Abstract][Full Text] [Related]
38. Absence of peripheral blood T cell responses to "shared epitope' containing peptides in recent onset rheumatoid arthritis.
McColl GJ; Hammer J; Harrison LC
Ann Rheum Dis; 1997 Apr; 56(4):240-6. PubMed ID: 9165996
[TBL] [Abstract][Full Text] [Related]
39. HLA-DRB1 genotype influences risk for and severity of rheumatoid arthritis.
Meyer JM; Evans TI; Small RE; Redford TW; Han J; Singh R; Moxley G
J Rheumatol; 1999 May; 26(5):1024-34. PubMed ID: 10332964
[TBL] [Abstract][Full Text] [Related]
40. Magnitude of structural changes of the T-cell receptor binding regions determine the strength of T-cell antagonism: molecular dynamics simulations of HLA-DR4 (DRB1*0405) complexed with analogue peptide.
Toh H; Kamikawaji N; Tana T; Muta S; Sasazuki T; Kuhara S
Protein Eng; 2000 Jun; 13(6):423-9. PubMed ID: 10877853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
